The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
Open accessAbstract
The Human Phenotype Ontology (HPO)-a standardized vocabulary of phenotypic abnormalities associated with 7000+ diseases-is used by thousands of researchers, clinicians, informaticians and electronic health record systems around the world. Its detailed descriptions of clinical abnormalities and computable disease definitions have made HPO the de facto standard for deep phenotyping in the field of rare disease. The HPO's interoperability with other ontologies has enabled it to be used to improve diagnostic accuracy by incorporating model organism data. It also plays a key role in the popular Exomiser tool, which identifies potential disease-causing variants from whole-exome or whole-genome sequencing data. Since the HPO was first introduced in 2008, its users have become both more numerous and more diverse. To meet these emerging needs, the project has added new content, language translations, mappings and computational tooling, as well as integrations with external community data. The HPO continues to collaborate with clinical adopters to improve specific areas of the ontology and extend standardized disease descriptions. The newly redesigned HPO website (www.human-phenotype-ontology.org) simplifies browsing terms and exploring clinical features, diseases, and human genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These genes demonstrated significant differences between AD and control samples.”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [68]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The model's validity was assessed using the top 20 and bottom 10 genes across three biologically distinct AD model systems (68).”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [68]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although constrained by input data that lacked non-human information, the AD-specific XGBoost model emphasized the role of infection as a critical factor in AD pathology.”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [68]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In this case, XGBoost, a form of extreme gradient boosting (67), was utilized to identify novel genes associated with Alzheimer's disease (68).”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [68]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach uncovered five previously unassociated gene targets related to immunity in AD: FRRS1 , CTRAM , SCGB3A1 , CIBAR2 , and TMEFF2.”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [68]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The model identified key variables associated with inflammatory processes and oxidative stress.”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [68]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“By integrating the comprehensive Pharos dataset, a web-based interface for data collected by the Illuminating the Druggable Genome initiative, into XGBoost, an AD-focused model was developed, which included 53 positive (AD-associated) and 3,952 negative (non-AD-associated) genes.”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [68]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical application of whole-exome sequencing across clinical indications
Retterer, K., Juusola, J., Cho, M. T., Vitazka, P., Millan, F., Gibellini, F., Vertino-Bell, A., Smaoui, N., Neidich, J., Monaghan, K. G., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.148 · Cited by 1,049
The human phenotype ontology: a tool for annotating and analyzing human hereditary disease
Robinson, P. N., Köhler, S., Bauer, S., Seelow, D., Horn, D., & Mundlos, S. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.017 · Cited by 1,034
Self-citationThe Human Phenotype Ontology project: linking molecular biology and disease through phenotype data
Köhler, S., Doelken, S., Mungall, C. J., Bauer, S., Firth, H., Bailleul-Forestier, I., Black, G., Brown, D. L., Brudno, M., Campbell, J., et al. (2013) · Nucleic Acids Res. · doi:10.1093/nar/gkt1026 · Cited by 840
Self-citationResolution of Disease Phenotypes Resulting from Multilocus Genomic Variation
Posey, J. E., Harel, T., Liu, P., Rosenfeld, J. A., James, R. A., Coban‐Akdemir, Z., Walkiewicz, M. A., Bi, W., Xiao, R., Ding, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516767 · Cited by 772
The Human Phenotype Ontology in 2017
Köhler, S., Vasilevsky, N., Engelstad, M., Foster, E. D., McMurry, J. A., Aymé, S., Baynam, G. S., Bello, S. M., Boerkoel, C. F., Boycott, K. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1039 · Cited by 767
Self-citationDeep phenotyping for precision medicine
Robinson, P. N. (2012) · Human Mutation · doi:10.1002/humu.22080 · Cited by 479
Self-citationThe Matchmaker Exchange: A Platform for Rare Disease Gene Discovery
Philippakis, A., Azzariti, D. R., Beltrán, S., Brookes, A. J., Brownstein, C. A., Brudno, M., Brunner, H. G., Buske, O. J., Carey, K., Doll, C., et al. (2015) · Human Mutation · doi:10.1002/humu.22858 · Cited by 476
Self-citationStudy, S. S., Singh, T., Study, I., Study, D., UK10 K Consortium, Kurki, M. I., Curtis, D., Purcell, S. M., Crooks, L., McRae, J., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4267 · Cited by 452
International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
Boycott, K. M., Rath, A., Chong, J. X., Hartley, T., Alkuraya, F. S., Baynam, G., Brookes, A. J., Brudno, M., Carracedo, A., den Dunnen, J. T., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.04.003 · Cited by 447
Self-citationMungall, C. J., McMurry, J. A., Köhler, S., Balhoff, J. P., Borromeo, C., Brush, M., Carbon, S., Conlin, T., Dunn, N., Engelstad, M., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1128 · Cited by 441
Self-citation
Cited by
Sorted by citations
Raudvere, U., Kolberg, L., Kuzmin, I., Arak, T., Adler, P., Peterson, H., & Vilo, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz369 · Cited by 5,045
Gene set knowledge discovery with enrichr
Xie, Z., Bailey, A., Kuleshov, M. V., Clarke, D. J. B., Evangelista, J. E., Jenkins, S. L., Lachmann, A., Wojciechowicz, M. L., Kropiwnicki, E., Jagodnik, K. M., et al. (2021) · Current Protocols · doi:10.1002/cpz1.90 · Cited by 3,451
The DisGeNET knowledge platform for disease genomics: 2019 update
Piñero, J., Ramírez-Anguita, J. M., Saüch-Pitarch, J., Ronzano, F., Centeno, E., Sanz, F., & Furlong, L. I. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1021 · Cited by 2,639
The Human Phenotype Ontology in 2021
Köhler, S., Gargano, M. A., Matentzoglu, N., Carmody, L., Lewis‐Smith, D., Vasilevsky, N., Daniš, D., Balagura, G., Baynam, G. S., Brower, A., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1043 · Cited by 1,149
Self-citationKolberg, L., Raudvere, U., Kuzmin, I., Vilo, J., & Peterson, H. (2020) · F1000Research · doi:10.12688/f1000research.24956.2 · Cited by 1,098
Metadata
- Authors
- Köhler, S., Carmody, L., Vasilevsky, N., Jacobsen, J. O. B., Danis, D., Gourdine, J.-P., Gargano, M., Harris, N. L., Matentzoglu, N., McMurry, J. A., Osumi-Sutherland, D., Cipriani, V., Balhoff, J. P., Conlin, T., Blau, H., Baynam, G., Palmer, R., Gratian, D., Dawkins, H., Segal, M., Jansen, A. C., Muaz, A., Chang, W. H., Bergerson, J., Laulederkind, S. J. F., Yüksel, Z., Beltran, S., Freeman, A. F., Sergouniotis, P. I., Durkin, D., Storm, A. L., Hanauer, M., Brudno, M., Bello, S. M., Sincan, M., Rageth, K., Wheeler, M. T., Oegema, R., Lourghi, H., Della Rocca, M. G., Thompson, R., Castellanos, F., Priest, J., Cunningham-Rundles, C., Hegde, A., Lovering, R. C., Hajek, C., Olry, A., Notarangelo, L., Similuk, M., Zhang, X. A., Gómez-Andrés, D., Lochmüller, H., Dollfus, H., Rosenzweig, S., Marwaha, S., Rath, A., Sullivan, K., Smith, C., Milner, J. D., Leroux, D., Boerkoel, C. F., Klion, A., Carter, M. C., Groza, T., Smedley, D., Haendel, M. A., Mungall, C., & Robinson, P. N.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- The Jackson Laboratory for Genomic Medicine (US)
- Oregon Health & Science University (US)
- Queen Mary University of London (GB)
- Monarch Initiative, monarchinitiative.org
- Lawrence Berkeley National Laboratory (US)
- European Bioinformatics Institute (GB)
- Oregon State University (US)
- University of North Carolina at Chapel Hill (US)
- The Kids Research Institute Australia (AU)
- Curtin University (AU)
- Government of Western Australia (AU)
- SimulConsult (US)
- Vrije Universiteit Brussel (BE)
- Garvan Institute of Medical Research (AU)
- University of Toronto (CA)
- National Institutes of Health (US)
- Marquette University (US)
- Bioscientia GmbH, Ingelheim, Germany
- CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Baldiri Reixac 4, Barcelona 08028, Spain
- Manchester Royal Eye Hospital (GB)
- Inserm (FR)
- Jackson Laboratory (US)
- Sanford Health (US)
- Stanford Medicine (US)
- University Medical Center Utrecht (NL)
- ICF, Rockville, MD, USA
- Newcastle University (GB)
- Mount Sinai School of Medicine, New York, NY, USA
- University College London (GB)
- Child Neurology Unit. Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
- University of Ottawa (CA)
- Hôpitaux Universitaires de Strasbourg (FR)
- Children's Hospital of Philadelphia (US)
- University of Connecticut (US)
- Corresponding author
- Robinson, Peter N
- ORCID
- Köhler, Sebastian
- Carmody, Leigh
- Vasilevsky, Nicole
- Jacobsen, Julius O B
- Gourdine, Jean-Philippe
- Gargano, Michael
- Harris, Nomi L
- Matentzoglu, Nicolas
- McMurry, Julie A
- Osumi-Sutherland, David
- Cipriani, Valentina
- Balhoff, James P
- Conlin, Tom
- Blau, Hannah
- Baynam, Gareth
- Palmer, Richard
- Segal, Michael
- Jansen, Anna C
- Bergerson, Jenna
- Laulederkind, Stanley J F
- Yüksel, Zafer
- Beltran, Sergi
- Freeman, Alexandra F
- Sergouniotis, Panagiotis I
- Storm, Andrea L
- Hanauer, Marc
- Brudno, Michael
- Bello, Susan M
- Sincan, Murat
- Rageth, Kayli
- Wheeler, Matthew T
- Oegema, Renske
- Thompson, Rachel
- Castellanos, Francisco
- Priest, James
- Lovering, Ruth C
- Hajek, Catherine
- Olry, Annie
- Notarangelo, Luigi
- Similuk, Morgan
- Zhang, Xingmin A
- Lochmüller, Hanns
- Dollfus, Hélène
- Rosenzweig, Sergio
- Marwaha, Shruti
- Rath, Ana
- Sullivan, Kathleen
- Smith, Cynthia
- Milner, Joshua D
- Boerkoel, Cornelius F
- Klion, Amy
- Carter, Melody C
- Groza, Tudor
- Smedley, Damian
- Haendel, Melissa A
- Mungall, Chris
- Robinson, Peter N
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-11-22
- Volume
- 47
- Issue
- D1
- Pages
- D1018-D1027
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC6324074
- OpenAlex
- W2901332105
- Cited by
- 677
- References
- 64
- Citations by year
- 2026: 27 · 2025: 49 · 2024: 57 · 2023: 68 · 2022: 108 · 2021: 157 · 2020: 134 · 2019: 72 · 2018: 2
- FWCI
- 33.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (publishedVersion, cc-by)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion, other-oa)
- Murdoch University Research Portal (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
- HAL (submittedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eSpace (Curtin University) (submittedVersion, cc-by)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- National Institutes of Health (OD #5R24OD011883, 1 OT3 OD02464-01 UNCCH)
- Forums for Integrative Phenomics (U13 CA221044-01)
- NCATS Data Translator (1OT3TR002019)
- NCATS National Center for Digital Health Informatics Innovation (U24 TR002306)
- British Heart Foundation (RG/13/5/30112)
- Division of Intramural Research NIAID (01GM1608)
- European Union ’s Horizon 2020 Research and Innovation Programme (779257)
- Topics
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Physical Sciences › Computer Science › Artificial Intelligence › Semantic Web and Ontologies
- Keywords
- Human Phenotype Ontology, phenotypic abnormalities, rare diseases, deep phenotyping, disease definition, ontology interoperability, Exomiser, variant interpretation, ontology mapping, clinical features, human genes
- MeSH terms
- Congenital Abnormalities, Whole Genome Sequencing, Humans, Phenotype, Genetic Variation, Computational Biology, Genetic Predisposition to Disease, Internet, Databases, Genetic, Rare Diseases, Knowledge Bases, Biological Ontologies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
